Skip to main content

HEAL Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Historical Note

Notice of Meeting publications are only available starting September 2003.

 
HOUSE OF COMMONS   CHAMBRE DES COMMUNES
2nd Session, 37th Parliament   2e Session, 37e législature
 
NOTICE OF MEETING   AVIS DE CONVOCATION
 
Standing Committee on Health   Comité permanent de la santé
 
AMENDED   MODIFIÉ
 
Meeting No. 69 Séance no 69
Tuesday, November 4, 2003 Le mardi 4 novembre 2003
9:00 a.m. to 12:00 p.m. 9 h 00 à 12 h 00
Room 371, West Block   Pièce 371, édifice de l'Ouest
(992-1192)   (992-1192)
 
  
 
Orders of the Day   Ordre du jour
 
 
Prescription Drugs Médicaments sur ordonnance
 
9:00 a.m. to 10:30 a.m. 9 h 00 à 10 h 30
 
Witnesses Témoins
 
Rx & D - Canada's Research-Based Pharmaceutical Companies Rx & D - Les compagnies de recherche pharmaceutique du Canada
 
Murray J. Elston, President Murray J. Elston, président
 
John Stewart, Chairman and Executive Vice-President and
General Manager of Purdue Pharma		 John Stewart, président du Conseil et Vice-président et
directeur général de Purdue Pharma
 
Nestor Nituch, Director of Clinical Research
Bristol Myers Squibb (BMS)		 Nestor Nituch, directeur de recherche clinique
Bristol Myers Squibb (BMS)
 
BIOTECanada BIOTECanada
 
Janet Lambert, President Janet Lambert, présidente
 
Suzanne Cadden, Vice President of Clinical and Regulatory Affairs
Lorus Therapeutics		 Suzanne Cadden, vice-présidente des affaires réglementaires et clinique
Lorus Therapeutics
 
Canadian Generic Pharmaceutical Association Association canadienne du médicament générique
 
Allan Oberman, Vice-Chair, President and Chief Executive Officer of Novopharm Ltd. Allan Oberman, vice-président, président et chef de la direction de Novopharm Ltée.
 
Jim Keon, President Jim Keon, président
 
10:30 a.m. to 12:00 p.m. 10 h 30 à 12 h 00
 
(In Camera) (À huis clos)
 
Consideration of Draft Report Étude de projet de rapport
 
 
Le greffier du Comité
José Cadorette ((613) 995-4108)
Clerk of the Committee
 
2003/11/03 2:43 p.m.   2003/11/03 14 h 43